scholarly article | Q13442814 |
P356 | DOI | 10.1097/MPG.0B013E318182E716 |
P698 | PubMed publication ID | 19330931 |
P50 | author | Hania Szajewska | Q55272508 |
Piotr Albrecht | Q56650251 | ||
P2093 | author name string | Agnieszka Topczewska-Cabanek | |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Helicobacter pylori | Q180556 |
Helicobacter pylori infectious disease | Q4497153 | ||
placebo | Q269829 | ||
placebo-controlled trial | Q108853737 | ||
P304 | page(s) | 431-436 | |
P577 | publication date | 2009-04-01 | |
P1433 | published in | Journal of Pediatric Gastroenterology and Nutrition | Q6295721 |
P1476 | title | Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children | |
P478 | volume | 48 |
Q58798841 | A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands |
Q37955181 | Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. |
Q37712802 | Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents |
Q89474499 | Are Synbiotics added to the Standard Therapy to eradicate Helicobacter pylori in Children Beneficial? A Randomized Controlled Study |
Q26784386 | Are probiotics useful in Helicobacter pylori eradication? |
Q39653740 | Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells |
Q38496942 | Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori |
Q38046762 | Clinical practice: Helicobacter pylori infection in childhood. |
Q38217016 | Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections |
Q36417791 | Effect of pretreatment with Lactobacillus gasseri OLL2716 on first‐line Helicobacter pylori eradication therapy |
Q43119946 | Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study |
Q39417196 | Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis |
Q35048716 | Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis |
Q90437970 | Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials |
Q36412003 | Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone |
Q37969593 | Indications for the Use of Probiotics in Gastrointestinal Diseases |
Q86923783 | Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children |
Q47858003 | Meta‐analysis: probiotics in antibiotic‐associated diarrhoea |
Q87105396 | Peptide Extracts from Cultures of Certain Lactobacilli Inhibit Helicobacter pylori |
Q38125810 | Probiotics and clinical effects: is the number what counts? |
Q91810388 | Probiotics and prebiotics in intestinal health and disease: from biology to the clinic |
Q24186991 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
Q24235039 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
Q91644124 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
Q26825005 | Probiotics for the treatment of Helicobacter pylori infection in children |
Q40403508 | Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis |
Q35375748 | Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis |
Q42040216 | Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol |
Q41159908 | Safety of probiotics and synbiotics in children under 18 years of age. |
Q47153405 | Scientific Opinion on the substantiation of a health claim related toLactobacillus rhamnosusGG and maintenance of normal defecation during antibiotic treatment pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
Q83523641 | Sequential Therapy Compared with Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Double-Blind, Randomized, Controlled Trial |
Q55023884 | Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. |
Q50759344 | Students in Training to Become Biology Teachers - a controlled phase II trial (NCT01567267) |
Q38178231 | Survey and Systematic Literature Review of Probiotics Stocked in Academic Medical Centers within the United States |
Q64083709 | Surveys of parents and clinicians concerning the minimally important difference of probiotic therapy for prevention of paediatric antibiotic-associated diarrhoea |
Q35771988 | Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. |
Q56910466 | The Probiotic for Alleviation of -Associated Gastric Pathology in East Africa |
Q46496414 | The Use of Probiotics in Helicobacter pylori Eradication Therapy |
Q34443924 | The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis |
Q35236908 | The effects of probiotics on treatment of Helicobacter pylori eradication in children |
Q26823347 | The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts |
Q37892763 | Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori. |
Search more.